1989
Copad is established in Egypt.

Est. 1989
Advancing pharmaceuticals, consumer health, and manufacturing across Egypt and beyond.
Corporate History
Founded in 1989, Copad began by representing international healthcare companies in Egypt before building its own manufacturing and toll-manufacturing capabilities. That transition strengthened control over quality, scale, and portfolio development, shaping today's diversified healthcare platform.
Copad is established in Egypt.
Representation of international healthcare companies and import-driven market entry.
Transition into own manufacturing and toll manufacturing.
Development of a multi-category product range spanning pharmaceuticals, supplements, and nutrition.
Copad approaches 40 years of healthcare progress.
Corporate History
Founded in 1989, Copad began by representing international healthcare companies in Egypt before building its own manufacturing and toll-manufacturing capabilities. That transition strengthened control over quality, scale, and portfolio development, shaping today's diversified healthcare platform.

Corporate Introduction
Since its establishment, Copad has evolved from healthcare representation and import activity into a full-scale operation spanning pharmaceutical manufacturing, product development, and consumer-health commercialization. The company's structure reflects a deliberate progression: from introducing global healthcare products into the Egyptian market, to building domestic manufacturing capability, to developing a broad and diversified product portfolio serving both clinical and consumer needs.
Today, Copad's operations are organized around therapeutic specialization, manufacturing reliability, and category expansion — a structure designed to support continued growth across the Egyptian and regional healthcare markets.
Read the Full Company ProfileDivisions Overview
Copad operates across four core divisions: Pharmaceuticals, Consumer Health, Animal Health, and Manufacturing & Partnerships. Each division addresses a distinct market need while operating within a unified corporate identity built on quality, consistency, and healthcare relevance.

A portfolio structured around clinical relevance
Therapy Areas Preview
Copad's pharmaceutical portfolio is structured across eight therapeutic areas: Central Nervous System, Orthopedics, Cardiometabolic Diseases, Gynecology and Andrology, Gastrointestinal Health, Ear-Nose-Throat, Pulmonology, and Immunology. This structure allows the company's clinical expertise to be understood by medical relevance rather than by product name alone.
Explore Therapy Areas
Own manufacturing and toll manufacturing
Manufacturing Preview
Copad's operations are supported by domestic manufacturing facilities and toll-manufacturing capacity, positioning the company as both a product developer and a manufacturing partner within the Egyptian pharmaceutical sector. Manufacturing quality, regulatory alignment, and operational discipline underpin every stage of production.
Quality
Regulatory alignment
Operational discipline
Insights Preview
Copad publishes educational content addressing disease awareness, nutritional guidance, and healthcare developments relevant to its therapeutic areas. Content is developed to inform rather than promote, in line with healthcare communication standards in Egypt.
Visit InsightsPartnership Preview
Copad works with distributors, export partners, and manufacturing collaborators across Egypt and the wider region. The company's growing manufacturing base and expanding product portfolio create a strong foundation for new commercial partnerships.
Partner With Us